BioCentury
ARTICLE | Clinical News

Retroviral vector with the gene for Fanconi anemia type C: Began a Phase I/II trial in six patients whose blood cells will be removed and transformed by the vec

June 5, 1995 7:00 AM UTC

Genetic Therapy Inc. (GTII), Gaithersburg, Md. Product: Retroviral vector with the gene for Fanconi anemia type C Indication: Fanconi anemia type C, a rare type of anemia Status: Began a Phase I/II t...